The purpose of this paper is to outline the Medicines and Healthcare Products Regulatory Agency’s (MHRA) data needs and use cases, focusing on the limitations of the current UK data landscape and how this a future Health Data Research Service (HDRS) could address these gaps.
Excerpt from the official page. The original is authoritative.